Global & China Biological API Drug Manufacturing Market Research by Company, Type & Application 2015-2026
- Report Code : HEY2457762
- Published On: Apr, 2021
- Category : Chemicals & Materials
- Pages : 93
-
Report estimates that the Biological API Drug Manufacturing market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.
In this report, Report discusses the Global & China industrial policies, economic environment, and the impact of covid-19 on the Biological API Drug Manufacturingindustry and its cost structure. Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.
Market Segment as follows:
Product Type Segmentation Includes
In-House manufacturing
Contract manufacturing
Application Segmentation Includes
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Others
Companies Includes
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics
The main contents of the report including:
Section 1:
Product definition, type and application, Global & China market overview;
Section 2:
Global & China Market competition by company;
Section 3:
Global & China sales revenue, volume and price by type;
Section 4:
Global & China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
Industrial policies & economic environment
Section 9:
Conclusion.
For any other requirements, please feel free to contact us for customized contents.
-
With tables and figures helping analyze worldwide Global & China Biological API Drug Manufacturing market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 In-House manufacturing
1.1.2.2 Contract manufacturing
1.1.3 Market by Application
1.1.3.1 Monoclonal Antibody (mAb) Therapies
1.1.3.2 Vaccines
1.1.3.3 Insulin Therapies
1.1.3.4 Interferon Therapies
1.1.3.5 Others1.2 Global & China Market Size & Forecast
1.2.1 Global Market (2015-2020 & 2021-2026)
1.2.2 China Market (2015-2020 & 2021-2026)
2 Global & China Market by Company2.1 Global Sales by Company
2.2 China Sales by Company
3 Global & China Market by Type3.1 Global Sales by Product Type
3.2 China Sales by Product Type
4 Global & China Market by Application4.1 Global Sales by Application
4.2 China Sales by Application
5 China Trade5.1 Export Overview
5.2 Import Overview
6 Key Companies List6.1 Lonza
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)6.2 Boehringer Ingelheim BioXcellence
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)6.3 Celltrion
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)6.4 DSM
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)6.5 Samsung BioLogics
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)6.6 Fujifilm Diosynth Biotechnologies
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Cytovance Biologics
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 AbbVie
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Baxter
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)6.10 CEPiA Sanofi
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 GSK
6.11.1 Company Information
6.11.2 Product Specifications
6.11.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.12 Pfizer CentreOne
6.12.1 Company Information
6.12.2 Product Specifications
6.12.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.13 Sandoz
6.13.1 Company Information
6.13.2 Product Specifications
6.13.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.14 Vetter
6.14.1 Company Information
6.14.2 Product Specifications
6.14.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.15 Wuxi Biologics
6.15.1 Company Information
6.15.2 Product Specifications
6.15.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
7 Industry Upstream7.1 Industry Chain
7.2 Upstream Overview
8 Policies & Market Environment8.1 Policies
8.1.1 Major Regions Policies
8.1.2 Policies in China8.2 Market Environment
8.2.1 Porter's Five Forces
8.2.2 Impact of COVID-19
9 Research Conclusion
-
The Global & China Biological API Drug Manufacturing Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Global & China Biological API Drug Manufacturing Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Global & China Biological API Drug Manufacturing has a wide range of applications, including
From 2025 to 2030, the Global & China Biological API Drug Manufacturing Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Global & China Biological API Drug Manufacturing Market as well as its distribution among its players
The latest version of the Global & China Biological API Drug Manufacturing Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
